Analysis Highlights Link Between Lymphoma and Glyphosate
EPA panelists, frustrated with the agency’s review process, publish their own analysis implicating the controversial herbicide’s role in non-Hodgkin lymphoma risk.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL
Use of maintenance therapy as a therapeutic strategy in posttransplant patients with HL and NHL is increasing in frequency -
Predicting PD-1/PD-L1 Immunotherapy Responses
Finding biomarkers that can broadly and reliably predict immunotherapy outcomes for patients with cancer remains an elusive “holy grail,” said Dr Ott. -
Treatment of Early FL More Effective With PET-Staging and Contemporary RT
Treatment of stage I/II follicular lymphoma (as determined by FDG-PET parameters) resulted in better freedom from progression and OS rates compared with historical numbers. -
Thawing Frozen Cancer Drug Labels
As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…
VIDEO SERIES
LYMPHOMA NEWS
Contrast-Enhanced MRI Characterization of Brain Cancers
Marginal Zone Lymphoma Presentation at Multiple Mucosal Sites May Be Linked to Poorer Outcomes
Molecular Characterization of Pediatric Follicular Lymphoma
“Real-World” Hospitalization Data on Patients Receiving CAR-T Cell Therapy
Overall Survival in Follicular Lymphoma With Complete Response Similar to General Population
Want to read more?
Please login or register first to view this content.
